1. Home
  2. CELU vs VATE Comparison

CELU vs VATE Comparison

Compare CELU & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Celularity Inc.

CELU

Celularity Inc.

N/A

Current Price

$1.21

Market Cap

34.5M

Sector

Health Care

ML Signal

N/A

Logo INNOVATE Corp.

VATE

INNOVATE Corp.

N/A

Current Price

$4.93

Market Cap

74.0M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
CELU
VATE
Founded
2016
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
34.5M
74.0M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
CELU
VATE
Price
$1.21
$4.93
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
28.0K
11.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,107,100,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$76.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.01
$4.05
52 Week High
$4.35
$9.01

Technical Indicators

Market Signals
Indicator
CELU
VATE
Relative Strength Index (RSI) 50.28 43.51
Support Level $1.21 $4.80
Resistance Level $1.33 $5.37
Average True Range (ATR) 0.12 0.22
MACD -0.00 -0.03
Stochastic Oscillator 45.17 23.74

Price Performance

Historical Comparison
CELU
VATE

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

About VATE INNOVATE Corp.

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.

Share on Social Networks: